| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/08/2001 | WO2001016178A1 MATERIALS AND METHODS FOR INHIBITION OF IgE PRODUCTION |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | WO2001016134A1 Selective antagonists of a2b adenosine receptors |
| 03/08/2001 | WO2001016123A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | WO2001016122A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | WO2001015683A1 Delayed-action form of administration containing tramadol saccharinate |
| 03/08/2001 | WO2001015682A1 Pharmaceutical tramadol salts |
| 03/08/2001 | WO2001015681A1 Oral pharmaceutical forms of administration with a delayed action |
| 03/08/2001 | WO2001015668A1 Controlled release pellet formulation |
| 03/08/2001 | WO2001015667A1 Oral dosage forms |
| 03/08/2001 | WO2001015554A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | WO2001015553A1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 03/08/2001 | WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | WO1999065449A8 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | DE19937537A1 Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate 2-substituted derivatives Dialkylaminoalkylbiphenyl |
| 03/08/2001 | CA2388560A1 Sustained-release form of administration containing tramadol saccharinate |
| 03/08/2001 | CA2384194A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383347A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | CA2382989A1 Materials and methods for inhibition of ige production |
| 03/08/2001 | CA2382449A1 Metal-containing compositions, preparations and uses |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/07/2001 | EP1081146A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1081135A2 1H-indole-3-glyoxylamide spla2 inhibitors |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/07/2001 | EP1080087A1 Novel 2-alkyl substituted imidazole compounds |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080078A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1079839A1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
| 03/07/2001 | EP1079830A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079807A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
| 03/07/2001 | EP1079806A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |
| 03/07/2001 | EP0730579B1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 03/07/2001 | CN1286258A Purine L-nucleoside, analogs and use thereof |
| 03/07/2001 | CN1286087A Nasal drops |
| 03/07/2001 | CN1062869C Prednisolone derivs |
| 03/07/2001 | CN1062854C Salmeterol kinafoate with controlled particulate size |
| 03/06/2001 | US6197958 Carboxylic acid derivatives, their preparation and use |
| 03/06/2001 | US6197824 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 03/06/2001 | US6197822 Neuropeptide antagonists |
| 03/06/2001 | US6197811 Synthetic derivatives of phomalactone, a known compound obtainable by fermentation of the fungus phomopsis sp, have activity as inhibitors of cytokine production in treatment of disorders requiring immunosuppression, for example |
| 03/06/2001 | US6197800 Hypotensive agents; cardiovascular disorders |
| 03/06/2001 | US6197794 Antiinflamamtory agents; immunology diseases |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197774 Therapy for asthma, skin disorders |
| 03/06/2001 | US6197762 Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders |
| 03/06/2001 | US6197752 Tetrahydrofuran or tetrahydropyran compound; therapy for autoimmune disease, antiallergens, antiinflammatory agents |
| 03/06/2001 | US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| 03/06/2001 | US6197584 Antisense modulation of CD40 expression |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197306 Herbal composition for the treatment of chronic obstructive pulmonary disease, bronchitis and respiratory disorders and a process for preparing the same |
| 03/06/2001 | US6197300 ftsZ |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/01/2001 | WO2001014886A2 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 03/01/2001 | WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/01/2001 | WO2001014375A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014360A2 Benzopyrans and benzothiopyrans as rar selective retinoid agonists |
| 03/01/2001 | WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 03/01/2001 | WO2001014353A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 03/01/2001 | WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014036A1 Process for producing fine medicinal substances |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013953A2 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist |
| 03/01/2001 | WO2001013917A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | WO2001013893A2 Use of simple amino acids to form porous particles |
| 03/01/2001 | WO2001013892A2 Large porous particles by spray-drying |
| 03/01/2001 | WO2001013891A2 Modulation of release from dry powder formulations |
| 03/01/2001 | WO2001013885A1 Method to produce powders for pulmonary or nasal administration |
| 03/01/2001 | WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000068223A8 Ureas and their use as cell adhesion modulators |
| 03/01/2001 | WO2000023037A8 Two chamber cartridge for atomizers |
| 03/01/2001 | DE19940740A1 Pharmazeutische Salze Pharmaceutical Salts |
| 03/01/2001 | DE19939980A1 Inhibitoren des Integrins alphavbeta¶3¶ Inhibitors of integrin alphavbeta¶3¶ |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | CA2715683A1 Synergistic combination |
| 03/01/2001 | CA2383559A1 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | CA2383491A1 Large porous particles by spray-drying |
| 03/01/2001 | CA2383371A1 P193 proteins and nucleic acids, and uses thereof |
| 03/01/2001 | CA2382821A1 Modulation of release from dry powder formulations |